Vection Technologies Ltd
ASX:VR1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Vection Technologies Ltd
ASX:VR1
|
AU |
|
A
|
Aurora Energy Metals Ltd
ASX:1AE
|
AU |
|
SBC Medical Group Holdings Inc
NASDAQ:SBC
|
US |
|
Lifecore Biomedical Inc
NASDAQ:LFCR
|
US |
|
Inghams Group Ltd
ASX:ING
|
AU |
|
Pan Global Resources Inc
XTSX:PGZ
|
CA |
|
Lunai Bioworks Inc
NASDAQ:LNAI
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is VR1's stock price target?
Not Available
VR1 doesn't have any price targets made by Wall Street professionals.
What is Vection Technologies Ltd's Revenue forecast?
Projected CAGR
-16%
For the last 10 years the
compound annual growth rate for
Vection Technologies Ltd's revenue is
22%.
The projected
CAGR
for the next 2 years is
-16%.